Complete Sequence of the IncA/C1 Plasmid pCf587 Carrying blaPER-2 from Citrobacter freundii

Antimicrobial Agents and Chemotherapy
Melina RuggieroGabriel Gutkind

Abstract

The blaPER-2-harboring plasmid pCf587 (191,541 bp) belongs to lineage IncA/C1 and is closely related to pRA1. It contains a large resistance island including the blaPER-2 gene between two copies of ISKox2-like elements, the toxin-antitoxin module pemK-pemI, several other resistance genes inserted within a Tn2 transposon, a Tn21-like structure, and a class 1 integron. pCf587 belongs to sequence type 13 (ST13), a new plasmid multilocus sequence typing (pMLST) ST.

References

Mar 1, 1971·Journal of General Microbiology·T AokiT Watanabe
Mar 1, 1996·Antimicrobial Agents and Chemotherapy·A BauernfeindJ M Casellas
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·M QuinterosUNKNOWN Microbiology Study Group
Jul 3, 2004·Genome Research·Aaron C E DarlingNicole T Perna
Mar 3, 2006·The Journal of Antimicrobial Chemotherapy·Giuseppe CelenzaMariagrazia Perilli
Jul 14, 2006·Emerging Infectious Diseases·Alessandra CarattoliGian Maria Rossolini
Apr 18, 2007·Antimicrobial Agents and Chemotherapy·Pablo PowerGabriel Gutkind
Feb 12, 2008·BMC Genomics·Ramy K AzizOlga Zagnitko
Jun 2, 2009·Journal of Bacteriology·W Florian FrickeJacques Ravel
Jul 4, 2012·Mobile Genetic Elements·Timothy J Johnson, Kevin S Lang
Jul 12, 2012·The Journal of Antimicrobial Chemotherapy·Ea ZankariMette Voldby Larsen
Aug 17, 2012·Current Pharmaceutical Design·Gabriel O GutkindMarcela Radice
Apr 17, 2013·Enfermedades infecciosas y microbiología clínica·Keite da Silva NogueiraLibera Maria Dalla-Costa
Dec 3, 2013·Nucleic Acids Research·Ross OverbeekRick Stevens
Jan 23, 2014·Antimicrobial Agents and Chemotherapy·Lorena Cristina Corrêa FehlbergLibera Maria Dalla-Costa
Apr 30, 2014·Antimicrobial Agents and Chemotherapy·Alessandra CarattoliHenrik Hasman
Mar 18, 2015·Antimicrobial Agents and Chemotherapy·Ruichao LiSheng Chen
Apr 18, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Rima BatahJean-Marc Rolain
Apr 26, 2015·Plasmid·Christopher J Harmer, Ruth M Hall
Nov 22, 2015·Bioinformatics·Dmitry AntipovPavel A Pevzner
Mar 24, 2016·Molecular Biology and Evolution·Sudhir KumarKoichiro Tamura
Jun 24, 2017·The Journal of Antimicrobial Chemotherapy·Ruichao LiSheng Chen

❮ Previous
Next ❯

Citations

Aug 31, 2019·Annals of the New York Academy of Sciences·Katlego KopotsaNontombi Marylucy Mbelle
Dec 1, 2019·International Journal of Antimicrobial Agents·Laura DabosThierry Naas
Oct 27, 2021·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Edgar Gonzales-EscalanteJose Di Conza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.